Clinical Trial Update: A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of BOL-303224 for acute bacterial conjunctivitis has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• BOL-303224

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Acute Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2009-08-13